Pericardial effusion interventions: Difference between revisions
Created page with "__NOTOC__ {{Pericardial effusion}} {{CMG}}; {{AE}} {{RAK}} ==Overview== ==Indications== ==References== {{Reflist|2}}" |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The mainstay of treatment for pericardial effusion is pericardial fluid drainage. Indications for [[pericardiocentesis]] or a [[pericardial window]] include c[[Cardiac tamponade|ardiac tamponade,]] for diagnostic purposes if there is suspected purulent, [[tuberculosis]], or [[Neoplastic pericarditis|neoplastic pericarditis,]] and the presence of a large, persistent, symptomatic pericardial effusion. | |||
==Indications== | ==Indications== | ||
The mainstay of treatment for pericardial effusion is pericardiocentesis. Pericardiocentesis is usually reserved for patients with either: | |||
* a pericardial effusion and evidence of hemodynamic compromise (ie, cardiac tamponade) | |||
** Urgent drainage of the pericardial effusion for therapeutic (and potentially diagnostic) purposes. | |||
* a pericardial effusion who are hemodynamically stable with no evidence of cardiac tamponade | |||
** do '''not''' require immediate drainage of the effusion for therapeutic purposes | |||
** sampling of the effusion may be indicated for diagnostic purposes in patients without a clear etiology for the effusion | |||
Indications for [[pericardiocentesis]] or a [[pericardial window]] include the following:<ref name="maisch2">{{cite journal | author= Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH | title= Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology | journal= Eur Heart J | year=2004 | pages=587–10 | volume=25 | issue=7 | pmid=15120056 | doi= 10.1016/j.ehj.2004.02.002}}</ref> | |||
*[[Cardiac tamponade]] | |||
*For diagnostic purposes if there is suspected purulent, [[tuberculosis]], or [[neoplastic pericarditis]] | |||
*The presence of a large, persistent, symptomatic pericardial effusion | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 01:16, 9 December 2019
|
Pericardial effusion Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pericardial effusion interventions On the Web |
|
American Roentgen Ray Society Images of Pericardial effusion interventions |
|
Risk calculators and risk factors for Pericardial effusion interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Roukoz A. Karam, M.D.[2]
Overview
The mainstay of treatment for pericardial effusion is pericardial fluid drainage. Indications for pericardiocentesis or a pericardial window include cardiac tamponade, for diagnostic purposes if there is suspected purulent, tuberculosis, or neoplastic pericarditis, and the presence of a large, persistent, symptomatic pericardial effusion.
Indications
The mainstay of treatment for pericardial effusion is pericardiocentesis. Pericardiocentesis is usually reserved for patients with either:
- a pericardial effusion and evidence of hemodynamic compromise (ie, cardiac tamponade)
- Urgent drainage of the pericardial effusion for therapeutic (and potentially diagnostic) purposes.
- a pericardial effusion who are hemodynamically stable with no evidence of cardiac tamponade
- do not require immediate drainage of the effusion for therapeutic purposes
- sampling of the effusion may be indicated for diagnostic purposes in patients without a clear etiology for the effusion
Indications for pericardiocentesis or a pericardial window include the following:[1]
- Cardiac tamponade
- For diagnostic purposes if there is suspected purulent, tuberculosis, or neoplastic pericarditis
- The presence of a large, persistent, symptomatic pericardial effusion
References
- ↑ Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology". Eur Heart J. 25 (7): 587–10. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.